PLSE
$10.62
Pulse Biosciences CS
($.97)
(8.37%)
PLSE
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.44)
Revenue:  $0.00 Mil
Monday
Nov 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when PLSE reports earnings?
Beat
Meet
Miss

Where is PLSE's stock price going from here?
Up
Flat
Down
Stock chart of PLSE
Analysts
Summary of analysts' recommendations for PLSE
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.